The selection of the TELE-ACS trial results for presentation at ACC 24 highlights the pioneering achievements of Imperial College London and SHL in advancing the field of telemedicine TEL AVIV, Israel & ZURICH & NEW YORK / Feb 01, 2024 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is excited to... Read More